Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
12.21
+1.99 (19.47%)
At close: Aug 28, 2025, 4:00 PM
12.49
+0.28 (2.29%)
After-hours: Aug 28, 2025, 7:59 PM EDT
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $22.95 million as of August 28, 2025.
Market Cap
22.95M
Enterprise Value
6.08M
1-Year Change
n/a
Ranking
Category
Stock Price
$12.21
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $22.95M, an increase of 112.76%. That is a compound annual growth rate of 205.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 22.95M | 311.25% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.11B |
| Johnson & Johnson | 422.54B |
| AbbVie | 367.30B |
| UnitedHealth Group | 273.78B |
| Novo Nordisk | 249.15B |
| AstraZeneca | 247.41B |
| Novartis AG | 245.07B |
| Abbott Laboratories | 228.64B |